{"title":"弱视治疗的范式转变","authors":"R. Sanet, Fcovd, Pilar Vergara Giménez, L. Press","doi":"10.31707/vdr2019.5.3.p155","DOIUrl":null,"url":null,"abstract":"Our goal in this perspective piece is to provide a framework of support for a paradigm\nshift in the approach to treatment of amblyopia. Older paradigms essentially conceived of amblyopia as a monocular phenomenon. The National Eye Institute of the National Institute of Health in the United States (NEI/NIH) characterizes amblyopia as “a medical term used when the vision in one of the eyes is reduced because the eye and the brain are not working together properly.","PeriodicalId":91423,"journal":{"name":"Vision development and rehabilitation","volume":"121 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Paradigm Shift in the Treatment of Amblyopia\",\"authors\":\"R. Sanet, Fcovd, Pilar Vergara Giménez, L. Press\",\"doi\":\"10.31707/vdr2019.5.3.p155\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Our goal in this perspective piece is to provide a framework of support for a paradigm\\nshift in the approach to treatment of amblyopia. Older paradigms essentially conceived of amblyopia as a monocular phenomenon. The National Eye Institute of the National Institute of Health in the United States (NEI/NIH) characterizes amblyopia as “a medical term used when the vision in one of the eyes is reduced because the eye and the brain are not working together properly.\",\"PeriodicalId\":91423,\"journal\":{\"name\":\"Vision development and rehabilitation\",\"volume\":\"121 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-09-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Vision development and rehabilitation\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.31707/vdr2019.5.3.p155\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vision development and rehabilitation","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.31707/vdr2019.5.3.p155","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Our goal in this perspective piece is to provide a framework of support for a paradigm
shift in the approach to treatment of amblyopia. Older paradigms essentially conceived of amblyopia as a monocular phenomenon. The National Eye Institute of the National Institute of Health in the United States (NEI/NIH) characterizes amblyopia as “a medical term used when the vision in one of the eyes is reduced because the eye and the brain are not working together properly.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
